Latest Breaking News On - 023completed - Page 1 : comparemela.com

Conference call scheduled for 4:30 p.m. ET today Three Additional Data Announcements Expected in 2023Completed Enrollment in Phase 2b VOYAGE Study of VK2809 for NASH and Fibrosis; Data Expected in. | April 26, 2023

Therapeutics incLigand pharmaceuticals incorporatedPrnewswire viking therapeutics incExchange commissionAdditional data announcements expectedData expectedPlacebo adjusted mean weight lossPromising safetyEvaluating highly differentiated oral formulationResults expectedPublic offeringCommon stock raising gross proceedsQuarter ended marchBrian lianAnnounce dataEvaluating oral formulation